Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of chikungunya arthritis with methotrexate
RBR-73fdfq5Phase 3Completed
- Sponsor
- José Kennedy Amaral Pereira
- Start
- Oct 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Chikungunya (CHIKV) and chikungunya arthritis comparing Methotrexate + dexamethasone + folic acid with Placebo + dexamethasone + folic acid (2 arms). Started Oct 2022; status: completed.
02
Drugs
methotrexate
03
Conditions
Chikungunya (CHIKV)chikungunya arthritis
Beyond the preview
Go deeper on RBR-73fdfq5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-73fdfq5.